Navigation Links
Biologists find diatom to reduce red tide's toxicity
Date:8/20/2008

It's estimated that the red tide algae, Karenia brevis, costs approximately $20 million per bloom in economic damage off the coast of Florida alone. Scientists at the Georgia Institute of Technology have found that a diatom can reduce the levels of the red tide's toxicity to animals and that the same diatom can reduce red tide's toxicity to other algae as well. If scientists can learn to use this process to reduce the toxicity of red tide, they could reduce the vast amount of economic damage done to the seafood and tourism industries. The research appears as articles in press for the Web sites of the journals Harmful Algae and the Proceedings of the Royal Society of London B.

"We found that red tide toxins can be metabolized by other species of phytoplankton. That holds true for both the brevetoxins that damage members of the animal kingdom and the as yet unknown allelopathic toxins that kill other competing species of algae," said Julia Kubanek, an associate professor with a joint appointment in Georgia Tech's School of Biology and School of Chemistry and Biochemistry.

Red tide is a dramatic case of an ecosystem that's out of control. In normal seawater, K. brevis makes up about 1 percent or less of the species, but during a red tide, that share increases to more than 90 percent. Filter feeders such as oysters, mussels and clams ingest the dinoflagellate and become unsafe to eat. Fish killed by the red tide wash on the shore, which can be contaminated and essentially unusable to tourists for months at a time.

Kubanek and her researchers found in previous work that the growth of the diatom Skeletonema costatum was only moderately suppressed by the brevetoxins released by the red tide. So, they figured that the diatom might have a way to deal with the toxins. According to their study, they were right.

In one experiment, detailed in the journal Harmful Algae, Kubanek's students grew the red tide algae along with the S. costatum diatom to test her group's hypothesis and found that the samples with both organisms had a smaller concentration of brevetoxin B than samples without the diatom. They also tested the algae with four different S. costatum diatom strains from around the world and came up with largely the same results. That suggests that evolutionary experience with the red tide algae was not necessary for the diatom to resist the toxins.

In another experiment, covered in Proceedings of the Royal Society B, they found that the red tide algae was able to reduce the growth of the S. costatum diatom, but that exposure of the red tide organism to S. costatum makes the red tide less toxic to microscopic algae. That suggests that the diatom is somehow able to reduce the potency of red tide's toxins.

"It could be that Skeletonema is degrading Karenia's allelopathic chemicals just like it degrades brevetoxins. Or, it could be that Skeletonema is stressing Karenia out, making it harder to produce allelopathic chemicals," said Kubanek.

What they do know is that the brevetoxins that harm oysters and other members of the animal kingdom aren't the whole story.

"We found that when we took seawater and added purified brevetoxins to it, the live algae didn't suffer much, so there must be other chemicals released by the red tide that are toxic to these algae," said Kubanek.

How that's done, isn't clear yet, but Kubanek and her group are currently working on finding the answer to that question.

"What we do know is that this diatom, S. costatum, is able to undermine these toxins produced by the red tide, as well as the brevetoxins that are known to kill vertebrate animals like fish and dolphins," said Kubanek.

If scientists such as Kubanek and her team can learn more about the strategies that microscopic algae use to reduce the toxicity of red tide, they might be able to use that knowledge to help reduce the poisonous effects the tide has on the animal kingdom, not to mention the damage it does to the seafood and tourism industries.


'/>"/>

Contact: David Terraso
david.terraso@comm.gatech.edu
404-385-2966
Georgia Institute of Technology
Source:Eurekalert  

Related biology news :

1. Model for angelman syndrome developed by University of Texas at Austin biologists
2. Caltech neurobiologists discover individuals who hear movement
3. Engineers create 3-D model to help biologists combat blue tongue virus
4. Plant biologists discover unexpected proteins affecting small RNAs
5. Biologists are from Mars, chemists are from Venus?
6. Biologists at UC San Diego identify key protein in cells self-eating function
7. Biologists surprised to find parochial bacterial viruses
8. Cell biologists announce child-care grants for scientist-parents at annual meeting
9. Ant parasite turns host into ripe red berry, biologists discover
10. Biologists find unusual plant gene: abstinence by mutual consent
11. Evolution is deterministic, not random, biologists conclude from multi-species study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biologists find diatom to reduce red tide's toxicity
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
Breaking Biology Technology: